Abstract
To study the efficacy and mechanism of action of the intragastric bubble, 1- to 5-ml silicone bubbles were surgically implanted into the stomachs of 10- to 12-week-old female rats. To test the hypothesis that the satiety effects of the implant are mediated by visceral sensory nerves, a subgroup was treated as neonates with the sensory neurotoxin capsaicin, 50 mg/kg subcutaneously. In control animals, the implants caused a transient decrease in body weight, compared to sham-implanted animals, most evident at three days and abolished by 18 days after operation. In contrast, capsaicin-treated animals did not lose weight in response to gastric implantation. Substance P was decreased in the vagus nerves of capsaicin-treated animals, confirming sensory denervation. At autopsy, all gastric implanted rats had enlarged stomachs. We conclude that intact sensory innervation is essential for weight loss in response to the gastric bubble.
Similar content being viewed by others
References
Nieben OG, Harboe H: Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1:198–199, 1982
Percival WL: “The balloon diet,” a noninvasive treatment for morbid obesity: Preliminary report of 108 patients. Can J Surg 27:135–136, 1984
Durrans D, Taylor TV, Pullan BR, Rose P: Intragastric balloon; short term solution to a long-term problem? J R Coll Surg (Edinburgh) 30:369–371, 1985
McFarland RJ, Grundy A, Gazet JC, Pilkington TRE: Intragastric balloon: A novel idea proved ineffective Br J Surg 74:137–139, 1987
Meshkinpour H, Hsu D, Farivar S: Effect of gastric bubble as a weight reduction device: A controlled, crossover study. Gastroenterology 95:589–592, 1988
Benjamin SB, Maher KA, Cattau EL, Collen MJ, Fleischer DE, Lewis JH, Ciarleglio CA, Earll JM, Schaffer S, Mirkin K, Cooper J, Altschul AM: Double-blind controlled trial of the Garren-Edwards gastric bubble: An adjunctive treatment for exogenous obesity. Gastroenterology 95:581–588, 1988
Barkin JS, Reiner DK, Goldberg RI, Phillips RS: Effects of gastric bubble implant on weight change with and without compliance with a behavior modification program. Am J Gastroenterol 83:930–934, 1988
Kramer FM, Stunkard AJ, Spiegel TA, Deren JJ, Velchik MG, Wadden TA, Marshall KA: Limited weight losses with a gastric balloon. Arch Intern Med 149:411–413, 1989
Hogan RB, Johnston JH, Long BW, Sones JQ, Hinton LA, Bunge J, Corrigan SA: A double-blind, randomized, shamcontrolled trial of the gastric bubble for obesity. Gastrointest Endosc 35:381–385, 1989
Geliebter A, Melton PM, Gage D, McCray RS, Hashim SA: Gastric balloon to treat obesity: A double-blind study in nondieting subjects. Am J Clin Nutr 51:584–588, 1990
Marshall JB, Schreiger H, Kolozsi W, Vasudeva R, Bacon BR, McCullough AJ, Holt S: A prospective, multi-center clinical trial of the Taylor intragastric balloon for the treatment of morbid obesity. Am J Gastroenterol 85:833–837, 1990
Mathus-Vliegen EMH, Tytgat GNJ, Veldhuyzen-Offermans EAML: Intragastric balloon in the treatment of supermorbid obesity. Gastroenterology 99:362–369, 1990
Durrans D, Taylor TV, Holt S: Intragastric device for weight loss. Effect on energy intake in dogs. Dig Dis Sci 36:893–896, 1991
Buck SH, Burks TF: The neuropharmacology of capsaicin: Review of some recent observations. Pharmacol Rev 38:179–226, 1986
Helke CJ, O'Donohue TL, Jacobowitz DM: Substance P as a baro- and chemoreceptor afferent neurotransmitter: Immunochemical and neurochemical evidence in the rat. Peptides 1:1–9, 1981
Katz DM, Karten HJ: Substance P in vagal sensory ganglia: Localization in cell bodies and pericellular arborizations J Comp Neurol 193:549–564, 1980
Lundberg JM, Hokfelt T, Kewenter J, Pettersson G, Ahlman H, Edin R, Dahlstrom A, Nilsson G, Terenius L, Uvnas-Wallenstein K, Said S: Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve. Gastroenterology 77:468–471, 1979
Fox JJ, Cohen BJ, Lowe FM: Laboratory animal medicine. American College of Laboratory Animal Medicine Series, 1984
Holzer-Petsche U, Lembeck F: Systemic capsaicin treatment impairs the micturition reflex in the rat. Br J Pharmacol 83:935–941, 1984
Sharkey KA, Williams RG, Shultzberg M, Dockray GJ: Sensory substance P innervation of the urinary bladder: Possible site of action of capsaicin in causing urine retention in rats. Neuroscience 10:861–868, 1983
MacLean DB: Abrogation of peripheral cholecystokininsatiety in the capsaicin treated rat. Regul Pep 11:321–333, 1985
Bray GA: Obesity. DM 26:1–85, 1980
Griffin WO: Gastric bypass for morbid obesity. Surg Clin North Am 59:1103–1112, 1979
McFarland RJ, Gazet JC, Pilkington TRE: A 13 year review of jejunoileal bypass. Br J Surg 72:81–87, 1985
Deutch JA: The stomach in food satiation and the regulation of appetite. Prog Neurobiol 10:135–153, 1978
Feurle GE, Tischbirck K, Helmstaedter V: Intragastric balloons causing gastric hypertrophy, G-cell hyperplasia, and raised serum gastrin levels in rats. Lancet 2:386, 1982
Smith GP, Jerome BJ, Cushin RE, Samansky KJ: Vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 213:1036–1037, 1981
Holzer P, Lippe ITH, Holzer-Petsche U: Inhibition of gastrointestinal transit due to surgical trauma or peritoneal irritation is reduced in capsaicin-treated rats. Gastroenterology 91:360–363, 1986
Skofitsch G, Lembeck F: Visceral pain mediated by capsaicin sensitive neurons. Naunyn-Schmiedeberg's Arch Pharmacol 313(suppl):R32, 1980
Miller JD: Intragastric prosthesis for management of obesity World J Surg. 6:492–493, 1982
Yang Y, Kuwano H, Okudaira Y, Kholoussy AM, Matsumoto T: Use of intragastric balloons for weight reduction; an experimental study. Am J Surg 153:265–269, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Northway, M.G., Geisinger, K.R., Gilliam, J.H. et al. Weight loss induced by gastric implant in rats. Digest Dis Sci 37, 1051–1056 (1992). https://doi.org/10.1007/BF01300286
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01300286